

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histone H3-K36 demethylation (GO:0070544) | 4.70938646 |
| 2 | nuclear pore complex assembly (GO:0051292) | 4.45521794 |
| 3 | histone H3-K9 demethylation (GO:0033169) | 4.00960476 |
| 4 | mitotic sister chromatid cohesion (GO:0007064) | 3.87596957 |
| 5 | nuclear pore organization (GO:0006999) | 3.82422921 |
| 6 | response to muramyl dipeptide (GO:0032495) | 3.80046115 |
| 7 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.75223819 |
| 8 | response to peptidoglycan (GO:0032494) | 3.74909291 |
| 9 | DNA synthesis involved in DNA repair (GO:0000731) | 3.74728038 |
| 10 | histone lysine demethylation (GO:0070076) | 3.68344886 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68110705 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.68110705 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68110705 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68110705 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68110705 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.68110705 |
| 17 | embryonic process involved in female pregnancy (GO:0060136) | 3.63594625 |
| 18 | histone demethylation (GO:0016577) | 3.61047950 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.58580973 |
| 20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.53049555 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.39283625 |
| 22 | protein dealkylation (GO:0008214) | 3.37314045 |
| 23 | protein demethylation (GO:0006482) | 3.37314045 |
| 24 | regulation of histone H3-K27 methylation (GO:0061085) | 3.32826262 |
| 25 | mitotic chromosome condensation (GO:0007076) | 3.28110047 |
| 26 | dosage compensation (GO:0007549) | 3.27184187 |
| 27 | hepatocyte apoptotic process (GO:0097284) | 3.26514420 |
| 28 | pore complex assembly (GO:0046931) | 3.22779159 |
| 29 | germinal center formation (GO:0002467) | 3.19009504 |
| 30 | histone H3-K4 trimethylation (GO:0080182) | 3.11522631 |
| 31 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.09585159 |
| 32 | positive regulation of granulocyte differentiation (GO:0030854) | 3.08628095 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.01508190 |
| 34 | negative regulation of cell killing (GO:0031342) | 2.97331375 |
| 35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.97331375 |
| 36 | negative regulation of DNA repair (GO:0045738) | 2.96909484 |
| 37 | cellular extravasation (GO:0045123) | 2.96057573 |
| 38 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.94937187 |
| 39 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.93880472 |
| 40 | regulation of RNA export from nucleus (GO:0046831) | 2.93357211 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.92746398 |
| 42 | response to laminar fluid shear stress (GO:0034616) | 2.92563787 |
| 43 | synapsis (GO:0007129) | 2.89017384 |
| 44 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.82239812 |
| 45 | B cell receptor signaling pathway (GO:0050853) | 2.82134919 |
| 46 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.80806031 |
| 47 | histone H3-K4 methylation (GO:0051568) | 2.71647526 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 2.70714771 |
| 49 | peptidyl-lysine trimethylation (GO:0018023) | 2.67241995 |
| 50 | definitive hemopoiesis (GO:0060216) | 2.67216296 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 2.67076644 |
| 52 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.65542735 |
| 53 | histone H4-K16 acetylation (GO:0043984) | 2.62163336 |
| 54 | histone H3-K9 modification (GO:0061647) | 2.60471582 |
| 55 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.58610129 |
| 56 | neutrophil mediated immunity (GO:0002446) | 2.52668253 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.52007186 |
| 58 | response to host (GO:0075136) | 2.52007186 |
| 59 | response to host defenses (GO:0052200) | 2.52007186 |
| 60 | T cell migration (GO:0072678) | 2.50865045 |
| 61 | COPII vesicle coating (GO:0048208) | 2.49367309 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 2.48384852 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.46095904 |
| 64 | negative regulation of anoikis (GO:2000811) | 2.43641861 |
| 65 | regulation of necroptotic process (GO:0060544) | 2.43433342 |
| 66 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.43328374 |
| 67 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.42623584 |
| 68 | response to host immune response (GO:0052572) | 2.42623584 |
| 69 | regulation of gamma-delta T cell activation (GO:0046643) | 2.42249832 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42197455 |
| 71 | RNA stabilization (GO:0043489) | 2.41776573 |
| 72 | mRNA stabilization (GO:0048255) | 2.41776573 |
| 73 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.41554530 |
| 74 | protein export from nucleus (GO:0006611) | 2.39657508 |
| 75 | B cell homeostasis (GO:0001782) | 2.38931366 |
| 76 | detection of external biotic stimulus (GO:0098581) | 2.37527840 |
| 77 | activation of Rac GTPase activity (GO:0032863) | 2.35788640 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.35740997 |
| 79 | cellular protein complex localization (GO:0034629) | 2.35398135 |
| 80 | leukotriene biosynthetic process (GO:0019370) | 2.35044518 |
| 81 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.32375811 |
| 82 | leukocyte aggregation (GO:0070486) | 2.30495886 |
| 83 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.29503963 |
| 84 | myeloid leukocyte mediated immunity (GO:0002444) | 2.29082752 |
| 85 | necroptotic process (GO:0070266) | 2.27880927 |
| 86 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.27523126 |
| 87 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.27155553 |
| 88 | corticosteroid receptor signaling pathway (GO:0031958) | 2.26646735 |
| 89 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.25156314 |
| 90 | negative regulation of necroptotic process (GO:0060546) | 2.24899727 |
| 91 | peptidyl-threonine phosphorylation (GO:0018107) | 2.24432407 |
| 92 | protein localization to chromosome, centromeric region (GO:0071459) | 2.23729952 |
| 93 | megakaryocyte development (GO:0035855) | 2.23725125 |
| 94 | detection of other organism (GO:0098543) | 2.21355202 |
| 95 | negative regulation of phagocytosis (GO:0050765) | 2.20859136 |
| 96 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.20083747 |
| 97 | Golgi transport vesicle coating (GO:0048200) | 2.19821419 |
| 98 | COPI coating of Golgi vesicle (GO:0048205) | 2.19821419 |
| 99 | energy homeostasis (GO:0097009) | 2.19418336 |
| 100 | regulation of chromatin binding (GO:0035561) | 2.19247102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.51518212 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.40973884 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.09991346 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.99464156 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.46324852 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.32159586 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75985250 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68245495 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62906699 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59378392 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58083775 |
| 12 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.40298821 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36478090 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35556856 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.22543602 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.18930181 |
| 17 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.09434136 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.06220298 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05024886 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.03959168 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.97069325 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 1.95402488 |
| 23 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.93219737 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.91516780 |
| 25 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.89683037 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89205753 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.86265148 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.85773401 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85707342 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.84362312 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.79917575 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.79114179 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77636334 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74943455 |
| 35 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.69994405 |
| 36 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.69569097 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66524511 |
| 38 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.58962317 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58563478 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53699655 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53581179 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53331855 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52159794 |
| 44 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48944315 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48524990 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46299863 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44943855 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.42115986 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.42023302 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41529096 |
| 51 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39937703 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39645183 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39016563 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38869789 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38107409 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37784365 |
| 57 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36960439 |
| 58 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.34738525 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34177100 |
| 60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.33753369 |
| 61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33113458 |
| 62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33088157 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32018129 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32016542 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30012740 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28550504 |
| 67 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.26623252 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26331557 |
| 69 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.24973152 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23772268 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21706265 |
| 72 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.21273019 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20285015 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20135626 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17233253 |
| 76 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.16645311 |
| 77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16220688 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15729144 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14265420 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13197799 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12249484 |
| 82 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12224711 |
| 83 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10396938 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10187718 |
| 85 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09985126 |
| 86 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09985126 |
| 87 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.08128825 |
| 88 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06331640 |
| 89 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.06076137 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05131379 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04350732 |
| 92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03906423 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03393527 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02343790 |
| 95 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.02223949 |
| 96 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01909704 |
| 97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01791722 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01293004 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00011218 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99872338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002009_preneoplasia | 2.94893295 |
| 2 | MP0005451_abnormal_body_composition | 2.89152768 |
| 3 | MP0003436_decreased_susceptibility_to | 2.59839680 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.59415288 |
| 5 | MP0008260_abnormal_autophagy | 2.45068423 |
| 6 | MP0008057_abnormal_DNA_replication | 2.44453507 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 2.43545228 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.42652625 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.41716091 |
| 10 | MP0005076_abnormal_cell_differentiation | 2.37166819 |
| 11 | MP0003303_peritoneal_inflammation | 2.37124765 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.33627562 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.19198494 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.02219829 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.01385366 |
| 16 | MP0004808_abnormal_hematopoietic_stem | 1.96568735 |
| 17 | MP0003724_increased_susceptibility_to | 1.96283160 |
| 18 | MP0003221_abnormal_cardiomyocyte_apopto | 1.88634387 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.87138533 |
| 20 | MP0003172_abnormal_lysosome_physiology | 1.84380895 |
| 21 | MP0001800_abnormal_humoral_immune | 1.80788760 |
| 22 | MP0003091_abnormal_cell_migration | 1.73764323 |
| 23 | MP0002398_abnormal_bone_marrow | 1.71245512 |
| 24 | MP0002006_tumorigenesis | 1.68549539 |
| 25 | MP0001853_heart_inflammation | 1.65534173 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.59771564 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.59642935 |
| 28 | MP0003828_pulmonary_edema | 1.57885079 |
| 29 | MP0002419_abnormal_innate_immunity | 1.54251484 |
| 30 | MP0000703_abnormal_thymus_morphology | 1.51679611 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.51476235 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.48371714 |
| 33 | MP0002723_abnormal_immune_serum | 1.46748186 |
| 34 | MP0004947_skin_inflammation | 1.45972787 |
| 35 | MP0001819_abnormal_immune_cell | 1.45062406 |
| 36 | MP0002405_respiratory_system_inflammati | 1.44744378 |
| 37 | MP0004233_abnormal_muscle_weight | 1.42782740 |
| 38 | MP0000716_abnormal_immune_system | 1.41702828 |
| 39 | MP0000858_altered_metastatic_potential | 1.38040006 |
| 40 | MP0000685_abnormal_immune_system | 1.36954409 |
| 41 | MP0002722_abnormal_immune_system | 1.35547098 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.35412827 |
| 43 | MP0005387_immune_system_phenotype | 1.30921396 |
| 44 | MP0001790_abnormal_immune_system | 1.30921396 |
| 45 | MP0003111_abnormal_nucleus_morphology | 1.30266497 |
| 46 | MP0000733_abnormal_muscle_development | 1.29617235 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.28641783 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.28520860 |
| 49 | MP0003077_abnormal_cell_cycle | 1.24428967 |
| 50 | MP0010307_abnormal_tumor_latency | 1.24199250 |
| 51 | MP0001730_embryonic_growth_arrest | 1.23805362 |
| 52 | MP0002429_abnormal_blood_cell | 1.23650648 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.20849340 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.20849340 |
| 55 | MP0004381_abnormal_hair_follicle | 1.20627619 |
| 56 | MP0004185_abnormal_adipocyte_glucose | 1.19957939 |
| 57 | MP0005025_abnormal_response_to | 1.15435110 |
| 58 | MP0005621_abnormal_cell_physiology | 1.15375774 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.15310892 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.13537497 |
| 61 | MP0001851_eye_inflammation | 1.12834525 |
| 62 | MP0010678_abnormal_skin_adnexa | 1.10318246 |
| 63 | MP0000350_abnormal_cell_proliferation | 1.09940190 |
| 64 | MP0009278_abnormal_bone_marrow | 1.08475796 |
| 65 | MP0008961_abnormal_basal_metabolism | 1.05442415 |
| 66 | MP0002132_abnormal_respiratory_system | 1.05376902 |
| 67 | MP0003984_embryonic_growth_retardation | 1.04984954 |
| 68 | MP0008007_abnormal_cellular_replicative | 1.04342325 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.04218911 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.02779007 |
| 71 | MP0005058_abnormal_lysosome_morphology | 0.99357457 |
| 72 | MP0003693_abnormal_embryo_hatching | 0.98165445 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.97719072 |
| 74 | MP0002088_abnormal_embryonic_growth/wei | 0.97612377 |
| 75 | MP0005464_abnormal_platelet_physiology | 0.97368511 |
| 76 | MP0005310_abnormal_salivary_gland | 0.97353897 |
| 77 | MP0002086_abnormal_extraembryonic_tissu | 0.95415833 |
| 78 | MP0010155_abnormal_intestine_physiology | 0.95031842 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.94197631 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 0.93832901 |
| 81 | MP0004197_abnormal_fetal_growth/weight/ | 0.93771925 |
| 82 | MP0001915_intracranial_hemorrhage | 0.93061124 |
| 83 | MP0005671_abnormal_response_to | 0.92513882 |
| 84 | MP0009764_decreased_sensitivity_to | 0.89854211 |
| 85 | MP0009703_decreased_birth_body | 0.89806428 |
| 86 | MP0005380_embryogenesis_phenotype | 0.89375940 |
| 87 | MP0001672_abnormal_embryogenesis/_devel | 0.89375940 |
| 88 | MP0000313_abnormal_cell_death | 0.88375996 |
| 89 | MP0005384_cellular_phenotype | 0.87801625 |
| 90 | MP0006054_spinal_hemorrhage | 0.86695955 |
| 91 | MP0000383_abnormal_hair_follicle | 0.85643372 |
| 92 | MP0009785_altered_susceptibility_to | 0.84224584 |
| 93 | MP0003786_premature_aging | 0.83694635 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.83169883 |
| 95 | MP0004264_abnormal_extraembryonic_tissu | 0.80497382 |
| 96 | MP0004957_abnormal_blastocyst_morpholog | 0.79024842 |
| 97 | MP0001873_stomach_inflammation | 0.78424513 |
| 98 | MP0003448_altered_tumor_morphology | 0.77800603 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.77234778 |
| 100 | MP0000003_abnormal_adipose_tissue | 0.76675360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spinal cord lesions (HP:0100561) | 3.85257685 |
| 2 | Syringomyelia (HP:0003396) | 3.85257685 |
| 3 | Asymmetry of the thorax (HP:0001555) | 3.07739655 |
| 4 | Recurrent viral infections (HP:0004429) | 2.94447038 |
| 5 | Abnormality of the fingertips (HP:0001211) | 2.87160753 |
| 6 | Viral hepatitis (HP:0006562) | 2.84681527 |
| 7 | Subacute progressive viral hepatitis (HP:0006572) | 2.84648109 |
| 8 | Shoulder girdle muscle weakness (HP:0003547) | 2.79703174 |
| 9 | Fatigue (HP:0012378) | 2.78432023 |
| 10 | Pelvic girdle muscle weakness (HP:0003749) | 2.67421574 |
| 11 | Broad face (HP:0000283) | 2.53310845 |
| 12 | Slow saccadic eye movements (HP:0000514) | 2.47475532 |
| 13 | Eczematoid dermatitis (HP:0000976) | 2.45216457 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38541381 |
| 15 | Long eyelashes (HP:0000527) | 2.35155757 |
| 16 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.32452854 |
| 17 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.32452854 |
| 18 | Deep philtrum (HP:0002002) | 2.32183913 |
| 19 | Colitis (HP:0002583) | 2.30742079 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29404853 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29404853 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 2.28788827 |
| 23 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.28492839 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.24684334 |
| 25 | Symptomatic seizures (HP:0011145) | 2.22125494 |
| 26 | Cellulitis (HP:0100658) | 2.16921636 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.15166692 |
| 28 | Subaortic stenosis (HP:0001682) | 2.15166692 |
| 29 | Bladder carcinoma (HP:0002862) | 2.12223717 |
| 30 | Bladder neoplasm (HP:0009725) | 2.12223717 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.12024136 |
| 32 | Chest pain (HP:0100749) | 2.11451816 |
| 33 | Spondylolisthesis (HP:0003302) | 2.08065302 |
| 34 | Cutaneous melanoma (HP:0012056) | 2.08009690 |
| 35 | Leiomyosarcoma (HP:0100243) | 2.07730473 |
| 36 | Uterine leiomyosarcoma (HP:0002891) | 2.07730473 |
| 37 | Micronodular cirrhosis (HP:0001413) | 2.05960008 |
| 38 | Prominent nose (HP:0000448) | 2.01996755 |
| 39 | Rimmed vacuoles (HP:0003805) | 2.00360742 |
| 40 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.96906452 |
| 41 | Difficulty running (HP:0009046) | 1.94866204 |
| 42 | T lymphocytopenia (HP:0005403) | 1.94494212 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 1.92671871 |
| 44 | Absent frontal sinuses (HP:0002688) | 1.92081456 |
| 45 | Renal cell carcinoma (HP:0005584) | 1.91915671 |
| 46 | Termporal pattern (HP:0011008) | 1.90233079 |
| 47 | Insidious onset (HP:0003587) | 1.90233079 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 1.89202954 |
| 49 | Sparse lateral eyebrow (HP:0005338) | 1.88342455 |
| 50 | Papillary thyroid carcinoma (HP:0002895) | 1.88038666 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 1.86724503 |
| 52 | Inflammation of the large intestine (HP:0002037) | 1.85131852 |
| 53 | Curly hair (HP:0002212) | 1.85124901 |
| 54 | Thyroid carcinoma (HP:0002890) | 1.84487842 |
| 55 | Meningitis (HP:0001287) | 1.84457970 |
| 56 | Hypoglycemic seizures (HP:0002173) | 1.83249704 |
| 57 | Recurrent skin infections (HP:0001581) | 1.82944093 |
| 58 | Sandal gap (HP:0001852) | 1.79900051 |
| 59 | Vasculitis (HP:0002633) | 1.78210668 |
| 60 | Limb-girdle muscle weakness (HP:0003325) | 1.77787134 |
| 61 | Basal cell carcinoma (HP:0002671) | 1.77755335 |
| 62 | Gastrointestinal infarctions (HP:0005244) | 1.76326771 |
| 63 | Neonatal hypoglycemia (HP:0001998) | 1.75101287 |
| 64 | Spontaneous hematomas (HP:0007420) | 1.74878761 |
| 65 | Flat acetabular roof (HP:0003180) | 1.74811334 |
| 66 | Abnormality of T cell number (HP:0011839) | 1.73773851 |
| 67 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.73192215 |
| 68 | Somatic mutation (HP:0001428) | 1.72726043 |
| 69 | Progressive hearing impairment (HP:0001730) | 1.72584921 |
| 70 | Upper motor neuron abnormality (HP:0002127) | 1.72291091 |
| 71 | Arterial thrombosis (HP:0004420) | 1.72264345 |
| 72 | Lower limb hyperreflexia (HP:0002395) | 1.72058559 |
| 73 | Gastrointestinal carcinoma (HP:0002672) | 1.71885459 |
| 74 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.71885459 |
| 75 | Overlapping toe (HP:0001845) | 1.71819874 |
| 76 | Hepatitis (HP:0012115) | 1.71819168 |
| 77 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.70820280 |
| 78 | Macroorchidism (HP:0000053) | 1.70205596 |
| 79 | Thoracolumbar scoliosis (HP:0002944) | 1.69670897 |
| 80 | Low anterior hairline (HP:0000294) | 1.69531836 |
| 81 | Increased connective tissue (HP:0009025) | 1.67956584 |
| 82 | Abnormality of macrophages (HP:0004311) | 1.67824830 |
| 83 | Granulocytopenia (HP:0001913) | 1.67009678 |
| 84 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.66366961 |
| 85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.64635902 |
| 86 | Thick nail (HP:0001805) | 1.63200687 |
| 87 | Prominent metopic ridge (HP:0005487) | 1.62030254 |
| 88 | Acute myeloid leukemia (HP:0004808) | 1.61849310 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 1.61792484 |
| 90 | Abnormality of T cell physiology (HP:0011840) | 1.61269259 |
| 91 | Acute hepatic failure (HP:0006554) | 1.61076840 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 1.60960948 |
| 93 | Long palpebral fissure (HP:0000637) | 1.60886655 |
| 94 | Dislocated radial head (HP:0003083) | 1.60691820 |
| 95 | Distal lower limb amyotrophy (HP:0008944) | 1.60348354 |
| 96 | Progressive sensorineural hearing impairment (HP:0000408) | 1.59868573 |
| 97 | Rhabdomyosarcoma (HP:0002859) | 1.59621263 |
| 98 | Narrow palate (HP:0000189) | 1.59083863 |
| 99 | Orchitis (HP:0100796) | 1.58376036 |
| 100 | Progressive external ophthalmoplegia (HP:0000590) | 1.57606650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.87068544 |
| 2 | SIK3 | 2.99656915 |
| 3 | RIPK4 | 2.79457235 |
| 4 | CDK12 | 2.74380808 |
| 5 | BRD4 | 2.44766805 |
| 6 | MAP2K3 | 2.27264055 |
| 7 | MAP3K14 | 2.19343663 |
| 8 | TRIB3 | 1.93904959 |
| 9 | IRAK4 | 1.92098696 |
| 10 | STK24 | 1.84717347 |
| 11 | MAP4K1 | 1.77256300 |
| 12 | SIK1 | 1.77207698 |
| 13 | BMPR2 | 1.75579861 |
| 14 | BLK | 1.70675223 |
| 15 | CDK6 | 1.69147760 |
| 16 | SCYL2 | 1.66750431 |
| 17 | KSR2 | 1.64412486 |
| 18 | IRAK3 | 1.59278048 |
| 19 | SMG1 | 1.57154395 |
| 20 | MAP3K10 | 1.54233391 |
| 21 | PDGFRA | 1.53573882 |
| 22 | EPHB1 | 1.49379585 |
| 23 | TTN | 1.47864849 |
| 24 | IRAK2 | 1.44861290 |
| 25 | IRAK1 | 1.44119037 |
| 26 | ERN1 | 1.35624364 |
| 27 | ZAP70 | 1.30580663 |
| 28 | MAP3K13 | 1.27314458 |
| 29 | TYK2 | 1.27097892 |
| 30 | NEK9 | 1.25402672 |
| 31 | SIK2 | 1.23894483 |
| 32 | MOS | 1.20985734 |
| 33 | ICK | 1.20022188 |
| 34 | YES1 | 1.18895705 |
| 35 | INSRR | 1.17248556 |
| 36 | MELK | 1.16311732 |
| 37 | PASK | 1.11962015 |
| 38 | CSK | 1.10013906 |
| 39 | STK10 | 1.07629704 |
| 40 | EEF2K | 1.07497006 |
| 41 | RPS6KA4 | 1.05711601 |
| 42 | IKBKE | 1.04542182 |
| 43 | JAK3 | 1.03776889 |
| 44 | FGFR3 | 1.03694789 |
| 45 | NEK1 | 1.01684203 |
| 46 | CAMK1D | 0.93730642 |
| 47 | JAK1 | 0.93542782 |
| 48 | JAK2 | 0.92917618 |
| 49 | BTK | 0.91168981 |
| 50 | CDK4 | 0.90910724 |
| 51 | PDGFRB | 0.90305811 |
| 52 | EIF2AK3 | 0.89547271 |
| 53 | KSR1 | 0.89410053 |
| 54 | MAP3K2 | 0.88577424 |
| 55 | SGK3 | 0.87555570 |
| 56 | TAOK2 | 0.86943087 |
| 57 | TSSK6 | 0.86682287 |
| 58 | HCK | 0.86564891 |
| 59 | CLK1 | 0.85827628 |
| 60 | DYRK3 | 0.85677031 |
| 61 | MARK3 | 0.85397288 |
| 62 | FGR | 0.84981382 |
| 63 | MARK2 | 0.82569913 |
| 64 | CAMK1G | 0.81075910 |
| 65 | TAOK1 | 0.79374064 |
| 66 | FGFR4 | 0.77449757 |
| 67 | CHUK | 0.76868631 |
| 68 | CSF1R | 0.73769351 |
| 69 | GRK6 | 0.68054114 |
| 70 | RET | 0.68007257 |
| 71 | MTOR | 0.67536968 |
| 72 | MAPK11 | 0.66853228 |
| 73 | RAF1 | 0.66434055 |
| 74 | STK38L | 0.65862886 |
| 75 | MAP3K6 | 0.65623561 |
| 76 | ERBB4 | 0.64540652 |
| 77 | DYRK1B | 0.63601981 |
| 78 | MAP3K3 | 0.63599774 |
| 79 | CDK9 | 0.62268888 |
| 80 | ALK | 0.61848014 |
| 81 | MET | 0.61845105 |
| 82 | MAP3K8 | 0.58617042 |
| 83 | TRPM7 | 0.58152308 |
| 84 | CDC42BPA | 0.58122980 |
| 85 | MAPK7 | 0.58060567 |
| 86 | MAP3K5 | 0.57295599 |
| 87 | PAK4 | 0.56721666 |
| 88 | EIF2AK1 | 0.56563245 |
| 89 | TBK1 | 0.54795863 |
| 90 | SYK | 0.54435449 |
| 91 | RPS6KB2 | 0.52254206 |
| 92 | CHEK1 | 0.52066276 |
| 93 | PTK6 | 0.52010335 |
| 94 | MAP3K1 | 0.50745650 |
| 95 | CDK7 | 0.50295795 |
| 96 | LRRK2 | 0.49032388 |
| 97 | CAMK4 | 0.47536941 |
| 98 | PIK3CG | 0.45470852 |
| 99 | WNK1 | 0.44937630 |
| 100 | LATS1 | 0.44925054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.22362841 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21361520 |
| 3 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.09086224 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.90701101 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89837148 |
| 6 | Hepatitis B_Homo sapiens_hsa05161 | 1.75409408 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.71185639 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69735781 |
| 9 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.69118328 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.68984813 |
| 11 | Prostate cancer_Homo sapiens_hsa05215 | 1.62269352 |
| 12 | Endometrial cancer_Homo sapiens_hsa05213 | 1.60906711 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60041226 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.55830838 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55100433 |
| 16 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.52441275 |
| 17 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.51964870 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.51112275 |
| 19 | Thyroid cancer_Homo sapiens_hsa05216 | 1.45822183 |
| 20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44158789 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.42477900 |
| 22 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.40703828 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.39411902 |
| 24 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.38164102 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38114174 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37274599 |
| 27 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.35228092 |
| 28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32083329 |
| 29 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.31750846 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28719806 |
| 31 | Glioma_Homo sapiens_hsa05214 | 1.28216113 |
| 32 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.27898826 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26438282 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 1.26366866 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.25782544 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.25421636 |
| 37 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.25393576 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24158953 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23686637 |
| 40 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.23457430 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21379042 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17131504 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.16063027 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 1.13400807 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.12650217 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.11656756 |
| 47 | Colorectal cancer_Homo sapiens_hsa05210 | 1.09747179 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08890133 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08203538 |
| 50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05617281 |
| 51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05053411 |
| 52 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.03543714 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02999457 |
| 54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.02297952 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 1.02017945 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98106692 |
| 57 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97057169 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.96673349 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.96315629 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96008558 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94071765 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90940728 |
| 63 | HTLV-I infection_Homo sapiens_hsa05166 | 0.90868120 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90756648 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.90325732 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89231400 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.88389921 |
| 68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86674304 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.86538960 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.85738430 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85161180 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83839663 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83541693 |
| 74 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.82054777 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.81387220 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79447035 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79396841 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75951093 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75277087 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74856663 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.74358873 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74082189 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70048907 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68617691 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65774179 |
| 86 | Spliceosome_Homo sapiens_hsa03040 | 0.65311868 |
| 87 | Focal adhesion_Homo sapiens_hsa04510 | 0.63609955 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61469812 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.59311864 |
| 90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57923505 |
| 91 | Melanoma_Homo sapiens_hsa05218 | 0.56904170 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.56151785 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55490722 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54948499 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53965696 |
| 96 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52747936 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51971150 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49939451 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49904542 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48331509 |

